mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.008 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.009 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.009 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.009 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |